Kingston, RI, United States of America

Harbans Lal

This inventor holds 1 USPTO granted patent. Top assignee: Richardson-Merrell Inc.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harbans Lal. Retrieved from https://idiyas.com/inventor/harbans-lal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harbans Lal: Innovator in Antidiarrheal Agents

Introduction

Harbans Lal is a notable inventor based in Kingston, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiarrheal agents. His work has the potential to impact the treatment of gastrointestinal disorders.

Latest Patents

Harbans Lal holds a patent for "Clonidine and lofexidine as antidiarrheal agents." This patent describes the use of clonidine and lofexidine, along with their pharmaceutically acceptable salts, as effective non-narcotic antidiarrheal agents. These compounds are known antihypertensives that exhibit potent antidiarrheal activity, surpassing that of conventional drugs like diphenoxylate.

Career Highlights

Lal is associated with Richardson-Merrell Inc., where he has been involved in research and development. His work focuses on innovative solutions for gastrointestinal issues, showcasing his commitment to improving patient care through scientific advancements.

Conclusion

Harbans Lal's contributions to the field of pharmaceuticals, particularly through his patent on antidiarrheal agents, highlight his role as an innovator. His work continues to pave the way for more effective treatments in gastrointestinal health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…